Pharmaceuticals

Seaport Therapeutics

SPTX.US released FY2024 Annual Earnings on April 10, 2026 (BJT) with actual revenue of USD 0 and EPS of USD -15.8292

SPTX.US released FY2025 Annual Earnings on April 10, 2026 (BJT) with actual revenue of USD 0 and EPS of USD -10.043

J-Star

VCI Global

AXIOM INTELLIGENCE ACQ CORP 1 ORD USD0.0001 CL A (SUBS/RTS) 10/06/2030

Momentus

QTREX Quantum

Ainos

BiomX

CPS Tech

PicoCELA

Co-Diagnostics

SPTX

<p>General Atlantic, L.P. has disclosed an 11.5% stake in Seaport Therapeutics, Inc. following its IPO. The firm filed a Schedule 13D on May 11, 2026, indicating a shift towards more active engagement with the company. General Atlantic plans to collaborate with shareholders and may suggest operational changes or board composition. A 180-day lock-up period restricts sales, but the firm may adjust its position post-lock-up. General Atlantic is known for investing in long-term growth in healthcare, technology, and life sciences sectors.</p>

TradingView

General Atlantic Discloses Investment at Seaport Therapeutics with 11.5% Stake

Seaport Therapeutics(SPTX.US)

General Atlantic Discloses Investment at Seaport Therapeutics with 11.5% Stake